# Peripartum Cardiomyopathy in Nigeria Registry

Study · id `cardio:ct-nct03081949` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03081949](<https://clinicaltrials.gov/study/NCT03081949>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03081949

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT03081949. Randomized; no masking; primary purpose treatment. Start 2017-06-12 (actual); primary completion 2019-06-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT03081949, source copy `cardio:ctgov-nct03081949-2021-01-22`, retrieved 2026-10-26)
- Started: 2017-06-12 (actual) (ClinicalTrials.gov record NCT03081949, source copy `cardio:ctgov-nct03081949-2021-01-22`, retrieved 2026-10-26)
- Primary completion: 2019-06-30 (actual) (ClinicalTrials.gov record NCT03081949, source copy `cardio:ctgov-nct03081949-2021-01-22`, retrieved 2026-10-26)
- Completion: 2019-12-31 (actual) (ClinicalTrials.gov record NCT03081949, source copy `cardio:ctgov-nct03081949-2021-01-22`, retrieved 2026-10-26)
- Countries: Nigeria (ClinicalTrials.gov record NCT03081949, source copy `cardio:ctgov-nct03081949-2021-01-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03081949-2021-01-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Peripartum Cardiomyopathy in Nigeria Registry
- Acronym: PEACE
- Condition: Peripartum Cardiomyopathy
- Intervention (Drug): Oral Sodium Selenite 200 µg/day for 3 months
- Lead sponsor: Aminu Kano Teaching Hospital
- Lead sponsor class: OTHER
- Collaborator: Nigerian Cardiac Society
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Peripartum cardiomyopathy (`core:peripartum-cardiomyopathy`)
- Registry lists this organization as the lead sponsor: Aminu Kano Teaching Hospital (`cardio:org-aminu-kano-teaching-hospital`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Selenium supplementation in patients with peripartum cardiomyopathy: a proof-of-concept trial (`cardio:pubmed-33087055`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d3dafd13d8b1ba6b27d6a26e24b0959e48cf49c00d2656ef2b93d3b04b5d9d1e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
